Core Insights - FMC Corporation has launched its fluindapyr technology with the approval of Tremisia fungicide in Ukraine, marking its first introduction in the EMEA region [1][9] - The approval allows FMC to access over 10 million hectares of Ukrainian farmland, enhancing disease management options for local growers [2][3][9] Product Launch and Market Impact - The Tremisia fungicide is designed to combat significant diseases such as Alternaria, Sclerotinia in sunflowers, and Septoria and rust in wheat [1][9] - Ukraine, being a major exporter of sunflower, oilseed rape, and wheat, is positioned to benefit from this advanced fungicide technology [2] Strategic Partnerships - FMC has partnered with Corteva to expand the use of fluindapyr in the U.S. corn and soybean markets, targeting tough foliar diseases [4] Financial Guidance - The company maintains its 2025 revenue guidance at $4.15-$4.35 billion, with adjusted EBITDA projected at $870-$950 million, reflecting a 1% increase at the midpoint [5] - Adjusted EPS remains unchanged at $3.26-$3.70, and free cash flow is expected to be between $200 million and $400 million [5] Stock Performance - FMC's stock has declined by 21.3% over the past year, contrasting with the industry's growth of 10.3% [6]

Core Insights - FMC Corporation has formed a strategic partnership with Corteva Agriscience to enhance the use of fluindapyr fungicide technology in the U.S. corn and soybean markets, aiming to assist farmers in combating challenging foliar diseases like tar spot and southern rust [1][8] Partnership Details - The agreement entails both companies marketing fluindapyr-based fungicides to corn and soybean growers across the U.S. FMC will continue to sell its Adastrio fungicide and develop additional fluindapyr products, while Corteva plans to launch its fluindapyr-based product at the start of the 2026 growing season, pending EPA registration [2][8] Market Impact - This partnership is expected to extend FMC's fluindapyr technology to a significant portion of the U.S. corn and soybean markets, which encompass approximately 95 million acres and 80 million acres of planted land, respectively, thereby providing farmers with advanced solutions for managing costly diseases and optimizing crop yields [3] Product Efficacy - Fluindapyr, the active ingredient in Adastrio fungicide, offers long-lasting control and effectively targets pathogens resistant to other fungicides. FMC has already introduced fluindapyr-containing products in several countries and plans to expand to additional markets, including Chile, Honduras, India, and Ukraine, subject to regulatory approvals [4] Financial Outlook - FMC has maintained its revenue outlook for 2025 at $4.15-$4.35 billion, with an adjusted EBITDA forecast of $870-$950 million, indicating a 1% increase at the midpoint from the previous year. The adjusted earnings per share outlook remains at $3.26-$3.70, and the free cash flow forecast is set at $200-$400 million [7]